This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jeffrey D. Bernhard, MD
Division of Dermatology University of Massachusetts Medical School 55 Lake Ave N Worcester, MA 01605

Arch Dermatol. 1985;121(1):26.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Despite its dramatic effectiveness in the treatment of cystic acne, relapses have occurred after treatment with oral isotretinoin.¹ I recently saw a patient who had a beneficial response to a four-month course of oral isotretinoin, but who had a "recurrence" of acne five months after drug therapy had been discontinued. Her new eruption was not a recurrence but was, instead, new-onset acne cosmetica.²

Report of a Case.—

A 19-year-old woman had cystic acne involving the face, chest, and back that was unresponsive to previous conventional treatment. In August 1983, she was started on an 80 mg/day regimen of oral isotretinoin. Within two months her condition had clearly improved; by the end of four months the appearance of new lesions had virtually ceased, and the isotretinoin therapy was discontinued.

The patient was seen again in June 1984, complaining of a "new rash" on her face. She . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?